Tuberculosis Screening in Paraguayan Prisons

NCT04407325 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2023-04-03

No results posted yet for this study

Summary

Two diagnostic tools for TB screening in high risk groups need additional assessment: the AeoNose™, an 'electronic nose device' for breath sampling, and digital chest X-ray (CXR) with computer aided detection with CAD4TB® software. This study will systematically screen prisoners and its' employees for TB, test the diagnostic performance of AeoNose™ and CAD4TB (both individually and together) as a TB screening tool and and establish Mycobacterium tuberculosis epidemiology in Paraguayan prisons.

Conditions

  • Volatile Organic Compounds
  • Radiography

Interventions

DEVICE

electronic nose device

electronic nose device will be tested as a triage instrument for tuberculosis in a high risk population

DEVICE

dig chest Xray with automated readings

software for tuberculosis detection on digital Chest Xray providing a probability score from 0-100

Sponsors & Collaborators

  • European Union

    collaborator OTHER
  • Instituto de Saude Publica da Universidade do Porto

    collaborator OTHER
  • VHIR

    collaborator UNKNOWN
  • University Medical Center Groningen

    collaborator OTHER
  • Laboratorio central de salud publica, Paraguay

    collaborator UNKNOWN
  • Instituto Nacional de Enfermedades Respiratorias y del Ambiente Juan Max Boetner

    collaborator UNKNOWN
  • National TB program Paraguay

    collaborator UNKNOWN
  • IICS Paraguay

    collaborator UNKNOWN
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Cecile Magis-Escurra, MD,PhD · Radboud University Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-18
Primary Completion
2023-07-01
Completion
2023-12-01

Countries

  • Paraguay

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407325 on ClinicalTrials.gov